In breast cancer, IGF-1R drives the occurrence of EMT (epithelial-mesenchymal transition) through FAK and NF-kappaB, which in turn helps cancer cells to invade and circulate for survival [48, 49]. Here, IGF1R is linked to breast carcinoma.